Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection
02 nov. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen to Announce Third Quarter Financial Results on November 10, 2020
27 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Showcases Six Scientific Presentations at ACR’s First Virtual Annual Meeting in November 2020
21 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced...
New Data Demonstrates Economic Benefit of Exagen’s AVISE® Lupus Test for Payors
12 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)
21 sept. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
03 sept. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome
03 août 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
27 juil. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen to Announce Second Quarter Financial Results on July 28, 2020
16 juil. 2020 10h45 HE
|
Exagen Inc.
SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus
03 juin 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...